EdeFrecskaMD

PubMed

• 24 citations
  N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain.
  Írisz Szabó, Viktória Varga, Szabolcs Dvorácskó, Attila Farkas, Tímea Körmöczi, Róbert Berkecz, Szilvia Kecskés, Ákos Menyhárt, Rita Frank, Dóra Hantosi, Nicholas V. C...> ;Neuropharmacology. 2021 May 21
• 7 citations
  Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia
  Réka Majer, Olar Adeyi, Zsuzsa Bagoly, Viktória Simon, László Csiba, László Kardos, Tibor Hortobágyi, Ede Frecska> ;Open Medicine. 2020 Sep 14
• 8 citations
  Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
  Zsombor Szoke-Kovacs, Csaba E. More, Rita Szoke-Kovacs, Endre Máthé, Ede Frecska> ;Neuropsychopharmacologia Hungarica. 2020 Mar 1
• 35 citations
  N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats.
  Sándor Nardai, Marcell László, Attila Szabo, Alán Alpár, János Hanics, Péter Zahola, Béla Merkely, Ede Frecska, Zoltán Zsolt Nagy> ;Experimental Neurology. 2020 Feb 14
• 9 citations
  N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.
  Balázs Nemes, Katalin Pető, Norbert Nemeth, Anita Mester, Zsuzsanna Magyar, Souleiman Ghanem, Viktoria Sogor, Bence Tanczos, Adam Deak, Márk Kállay, László Bidiga, Ede...> ;Transplantation Proceedings. 2019 May 1
• 19 citations
  Behavioural and Psychological Symptoms in Neurocognitive Disorders: Specific Patterns in Dementia Subtypes.
  Réka Majer, Viktória Simon, László Csiba, László Kardos, Ede Frecska, Tibor Hortobágyi> ;Open Medicine. 2019 Apr 4
• 8 citations
  Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model.
  Katalin Peto, Norbert Nemeth, Anita Mester, Zsuzsanna Magyar, Souleiman Ghanem, Viktoria Somogyi, Bence Tanczos, Adam Deak, László Bidiga, Ede Frecska, Balázs Nemes> ;Clinical Hemorheology and Microcirculation. 2018 Jan 1
• 79 citations
  The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
  Botond Penke, Lívia Fülöp, Maria Szucs, Ede Frecska> ;Current Neuropharmacology. 2017 Dec 31
• 4 citations
  Validation of the Hungarian version of the Test Your Memory.
  László Róbert Kolozsvári, Zoltán Kovács, Gergő József Szőllősi, Szilvia Harsányi, Ede Frecska, Anikó Égerházi> ;Ideggyogyaszati Szemle. 2017 Jul 1
• [Ketamine administration in case of severe, therapy resistant depressed patient, case report].
  Szabolcs Morvai, Attila Nagy, Adrienn Bálint-Szöllősi, Csaba E. Móré, Roland Berecz, Ede Frecska> ;Ideggyogyaszati Szemle. 2016 Nov 30
• 60 citations
  The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human pr...
  Attila Szabo, Attila Kovács, Jordi Riba, Srdjan Djurovic, Éva Rajnavölgyi, Ede Frecska> ;Frontiers in Neuroscience. 2016 Sep 14
• The potential use of ayahuasca in psychiatry
  Ede Frecska, Petra Bokor, Gábor Andrássy, Attila Kovács> ;Neuropsychopharmacologia Hungarica. 2016 Jun 1
• ['Hit and run': The old paradigm of psychopharmacology in a new coat' - Editorial].
  Ede Frecska, Andras Perenyi> ;Neuropsychopharmacologia Hungarica. 2016 Mar 1
• 98 citations
  The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
  Ede Frecska, Petra Bokor, Michael Winkelman> ;Frontiers in Pharmacology. 2016 Mar 2
• 9 citations
  Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
  Attila Szabo, Ede Frecska> ;Neural Regeneration Research. 2016 Mar 1
• 1 citations
  UNANSWERED QUESTIONS IN THE TRANSCRANIAL MAGNETIC STIMULATION TREATMENT OF PATIENTS WITH DEPRESSION.
  Szabolcs Morvai, Attila Nagy, Attila Kovács, Csaba E. More, Roland Berecz, Ede Frecska> ;Ideggyogyaszati Szemle. 2016 Jan 30
• 2 citations
  [Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].
  Attila Szabo, Anita Kazai, Ede Frecska, Zoltán Brys> ;Neuropsychopharmacologia Hungarica. 2015 Sep 1
• Holistic approach in ancient Egypt
  Gábor Andrássy, Emese Kulcsár, Erzsébet Magyar, Ede Frecska> ;Lege Artis Medicinae. 2015 Mar 1
• 2 citations
  Relapse and insomnia in unipolar major depression
  Linda Falussy, Petra Balla, Ede Frecska> ;Neuropsychopharmacologia Hungarica. 2014 Sep 1
• 91 citations
  Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monoc...
  Attila Szabo, Attila Kovács, Ede Frecska, Éva Rajnavölgyi> ;Plos One. 2014 Aug 29
• 4 citations
  [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
  Zoltán Asztalos, Luca Egervári, Gábor Andrássy, Gabor Faludi, Ede Frecska> ;Neuropsychopharmacologia Hungarica. 2014 Mar 1
• 61 citations
  A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity
  Ede Frecska, Attila Szabo, Michael Winkelman, Luis E. Luna, Dennis J. McKenna> ;Journal of Neural Transmission. 2013 Apr 26
• 13 citations
  Automated Neuropsychological Test Battery in depression -- preliminary data.
  Anikó Égerházi, Petra Balla, Andrea Ritzl, Zsófia Varga, Ede Frecska, Roland Berecz> ;Neuropsychopharmacologia Hungarica. 2013 Mar 1
• [Observations of MDPV users: a prospective-retrospective study].
  Gábor Andrássy, Zoltán Asztalos, Anikó Égerházi, Ede Frecska> ;Psychiatria Hungarica. 2013 Jan 1
• 2 citations
  The message of the survival curves: I. Composite analysis of long-term treatment studies in bipolar disorder.
  Ede Frecska, Attila Kovács, Petra Balla, Linda Falussy, Akos Ferencz, Zsófia Varga> ;Neuropsychopharmacologia Hungarica. 2012 Sep 1
• Join now to see all